Biosynthesis of Nucleic Acids

Purine biosynthesis begins with ribose-5-phosphate, a pentose sugar derived from the pentose phosphate pathway. PRPP synthetase phosphorylates ribose-5-phosphate to form phosphoribosyl pyrophosphate (PRPP), the activated substrate upon which the purine ring is gradually assembled through sequential enzymatic reactions and enzymatic steps.

Purine biosynthesis builds the ring structure onto PRPP, forming inosine monophosphate (IMP) as the common precursor. Pyrimidine biosynthesis constructs the nitrogenous base first—using aspartate, glutamine, and bicarbonate—then attaches it to PRPP to form uridine monophosphate (UMP), the central pyrimidine precursor.

The purine ring derives nitrogen from glutamine and aspartate, while carbon atoms come from glycine, formate via tetrahydrofolate derivatives, and bicarbonate. These precursors are sequentially incorporated through enzymatic reactions to build the complete purine structure on the PRPP backbone during the biosynthetic pathway.

Accumulated purine and pyrimidine nucleotides inhibit key regulatory enzymes to prevent excessive synthesis. ATP and GTP inhibit PRPP synthetase and glutamine phosphoribosyl amidotransferase in purine pathways, while UTP inhibits carbamoyl phosphate synthetase II and CTP inhibits CTP synthetase in pyrimidine pathways, maintaining nucleotide homeostasis.

Thymidylate synthase catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), using N5, N10-methylene tetrahydrofolate as a methyl donor. This reaction produces the thymine nucleotide essential for DNA synthesis and is a target for chemotherapy drugs like methotrexate.

Proper nucleotide biosynthesis ensures adequate DNA and RNA synthesis for cell division, repair, and gene expression. Disruptions cause pathological conditions: cancer cells exhibit uncontrolled synthesis, adenosine deaminase deficiency leads to severe combined immunodeficiency, and imbalances contribute to neurodevelopmental and mitochondrial diseases.

IMP serves as the common precursor for both AMP and GMP through distinct pathways. AMP synthesis requires aspartate and energy from GTP, while GMP synthesis requires glutamine and energy from ATP. This branching allows cells to regulate purine nucleotide production independently based on metabolic demands.